Literature DB >> 30852128

Electromyography activity level in rapid eye movement sleep predicts neurodegenerative diseases in idiopathic rapid eye movement sleep behavior disorder: a 5-year longitudinal study.

Yaping Liu1, Jihui Zhang2, Siu Ping Lam1, Mandy Wai Man Yu1, Shirley Xin Li3, Junying Zhou4, Ngan Yin Chan5, Jing Wang1, Hongliang Feng1, Anne Chan6, Vincent Mok6, Yun Kwok Wing1.   

Abstract

OBJECTIVES: To investigate whether baseline electromyography (EMG) activity during rapid eye movement (REM) sleep predicts the development of neurodegenerative diseases over time in patients with idiopathic REM sleep behavior disorder (iRBD).
METHODS: A total of 216 patients with polysomnography-confirmed iRBD were recruited from September 1997 to December 2016 with a mean follow-up duration of 5.0 ± 3.7 years (median: 4.0, range: 0.5-19.0). Neurodegenerative diseases were ascertained according to standard diagnostic criteria during follow-up. Time-dependent receiver operating characteristic (ROC) curves were employed to evaluate the dynamic predictive performance of EMG activity over time. Both tonic and phasic EMG activity were dichotomized into 'mild' and 'severe' categories by the ROC curves estimated optimal cut-offs.
RESULTS: A total of 58 patients (26.9%) developed neurodegenerative diseases. The predictive performance of tonic EMG activity was stable (area under the curve of approximately 0.68) over time, while the performance of phasic EMG activity was significantly superior to chance only after five years of follow-up. The optimal cut-off for prediction at five years was 15.4% (sensitivity, 0.69; specificity, 0.57) and 7.8% (sensitivity, 0.79; specificity, 0.47) for tonic and phasic EMG activity, respectively. Cox proportional hazards regression analyses further revealed that severe tonic (adjusted HR: 2.76, 95% CI: 1.35-5.62) and phasic EMG activity (adjusted HR: 3.10, 95% CI: 1.10-8.71) were associated with early development of Parkinson's disease (PD) and dementia with Lewy bodies (DLB), respectively.
CONCLUSIONS: Tonic but not phasic EMG activity may serve as a stable biomarkers for predicting the progression of neurodegeneration in iRBD.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Neurodegenerative diseases; REM sleep behavior disorder; REM sleep without atonia; Time-dependent receiver operating characteristic

Mesh:

Substances:

Year:  2019        PMID: 30852128     DOI: 10.1016/j.sleep.2019.01.018

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  5 in total

1.  Generalized EEG Slowing Across Phasic REM Sleep, Not Subjective RBD Severity, Predicts Neurodegeneration in Idiopathic RBD.

Authors:  Si-Yi Gong; Yun Shen; Han-Ying Gu; Sheng Zhuang; Xiang Fu; Qiao-Jun Wang; Cheng-Jie Mao; Hua Hu; Yong-Ping Dai; Chun-Feng Liu
Journal:  Nat Sci Sleep       Date:  2022-03-11

2.  Personality profile and its association with conversion to neurodegenerative disorders in idiopathic REM sleep behavior disorder.

Authors:  Li Zhou; Steven W H Chau; Yaping Liu; Jing Wang; Jihui Zhang; Ngan Yin Chan; Joey W Y Chan; Bei Huang; Sijing Chen; Shirley Xin Li; Vincent Chung Tong Mok; Yun Kwok Wing
Journal:  NPJ Parkinsons Dis       Date:  2022-07-14

3.  Association of heart rate variability with REM sleep without atonia in idiopathic REM sleep behavior disorder.

Authors:  Jeong Hun Yang; Sang Ho Choi; Mi Hyun Lee; Seong Min Oh; Jae-Won Choi; Jee Eun Park; Kwang Suk Park; Yu Jin Lee
Journal:  J Clin Sleep Med       Date:  2021-03-01       Impact factor: 4.062

4.  Relations of non-motor symptoms and dopamine transporter binding in REM sleep behavior disorder.

Authors:  Petr Dušek; Veronika Lorenzo Y Losada Ibarburu; Ondrej Bezdicek; Irene Dall'antonia; Simona Dostálová; Petra Kovalská; Radim Krupička; Jiří Nepožitek; Tomáš Nikolai; Michal Novotný; Pavla Peřinová; Jan Rusz; Tereza Serranová; Tereza Tykalová; Olga Ulmanová; Zuzana Mecková; Václav Ptáčník; Jiří Trnka; David Zogala; Evžen Růžička; Karel Šonka
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

Review 5.  Predictors of RBD progression and conversion to synucleinopathies.

Authors:  Edoardo Rosario de Natale; Heather Wilson; Marios Politis
Journal:  Curr Neurol Neurosci Rep       Date:  2022-03-11       Impact factor: 5.081

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.